Conversations in Lung Cancer Research

By Thoracic Oncology Group Of Australasia (TOGA)

Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and t... more

· Medicine
· Health & Fitness

FAQs about Conversations in Lung Cancer Research:

How many episodes does Conversations in Lung Cancer Research have?

The podcast currently has 75 episodes available.

Conversations in Lung Cancer Research episodes:

November 14, 2024 Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NEC), and provide insights into the management of these patients and future treatment developments.

Associate Professor Rachel Wong, Deputy Director Oncology Eastern Health and Medical Oncologist at Epworth East in Melbourne is joined by Dr Patrick Hosking, Senior Histopathologist at Eastern Health Pathology; Dr Mal Itchins, Thoracic Medical Oncologist at Royal North Shore Hospital and Chris O'Brien LifeHouse in Sydney and Dr Sagun Parakh, Medical Oncologist at the Austin Hospital, Lung Cancer Lead.
https://www.omico.com.au/our-programs/cancer-screening-program-casp/ ---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you
enjoyed this episode, please rate and review us on Apple Podcasts or
Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at
https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at
https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn:
https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges
Traditional Owners of Country throughout Australia and recognises the
continuing connection to lands, waters and communities. We pay our
respect to Aboriginal and Torres Strait cultures; and to Elders past and
present.
...more
24min
September 30, 2024 Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
...more
19min
August 30, 2024 NTRK1, 2,3 And Other Rare Mutations In NSCLC
In this TOGA podcast, we provide an overview of the treatment options for rare subtypes of oncogene driven NSCLC that are now readily identified in the MBS-reimbursed small gene panel including NTRK1, 2,3 and other rare mutations in NSCLC. The importance of testing all patients is discussed as well as what to do when resistance occurs.

Associate Professor Steven Kao, Medical Oncologist from Chris O’Brien Lifehouse and Clinical Associate Professor Sydney Medical School, Faculty of Medicine and Health is joined by Professor Wendy Cooper, senior staff specialist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital in Sydney, Anatomical Clinical Stream Lead for NSW Health Pathology, a Clinical Professor at the University of Sydney and a Conjoint Professor at the University of Western Sydney and also Professor Ben Solomon head of the lung Medical Oncology Service and a Group Leader of the Molecular Therapeutics and Biomarkers Laboratory in the Research Division at Peter MacCallum Cancer Centre as well as a Founding Board member of TOGA. ---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you
enjoyed this episode, please rate and review us on Apple Podcasts or
Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at
https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at
https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn:
https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges
Traditional Owners of Country throughout Australia and recognises the
continuing connection to lands, waters and communities. We pay our
respect to Aboriginal and Torres Strait cultures; and to Elders past and
present.
...more
22min
July 25, 2024 Decoding Perioperative Immunotherapy In NSCLC
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment and the current reimbursement landscape. Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney, is joined by Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth and Mr Naveed Alam, Thoracic Surgeon from St Vincents, Epworth and Monash in Melbourne.
Many emerging treatments are discussed in this podcast, and clinicians are reminded that oncology access programs are listed in the medicines access portal https://www.medicinesap.com/ ---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you
enjoyed this episode, please rate and review us on Apple Podcasts or
Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at
https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at
https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn:
https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges
Traditional Owners of Country throughout Australia and recognises the
continuing connection to lands, waters and communities. We pay our
respect to Aboriginal and Torres Strait cultures; and to Elders past and
present.
...more
22min
July 18, 2024 Decoding Perioperative Immunotherapy in NSCLC
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment and the current reimbursement landscape. Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney, is joined by Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth and Mr Naveed Alam, Thoracic Surgeon from St Vincents, Epworth and Monash in Melbourne.
Many emerging treatments are discussed in this podcast, and clinicians are reminded that oncology access programs are listed in the medicines access portal https://www.medicinesap.com/
...more
22min
June 19, 2024 Access to New Medicines: Which Surrogate Endpoints Matter
Do we need to evolve the bar on evidence required for drug reimbursement? The gold standard endpoint for assessing the benefit of anti-cancer drugs has been overall survival (OS) however, more recently, there has been a trend toward using surrogate clinical trial endpoints such as progression free survival (PFS) and event-free survival (EFS). As treatments improve and patients are living longer, using OS as a primary endpoint can mean a longer time until a result is obtained. In this podcast, Dr Rebecca Tay, Medical Oncologist at Royal Hobart Hospital and ICON, discusses the critical role of improvement in quality of life in assessing drugs that are funded on the PBS, the nuances around clinical trial endpoints and the need for surrogate endpoints that accurately predict for OS and a reimbursement system that brings beneficial treatments to patients faster. Professor Nick Pavlakis, Chair of TOGA and Medical Oncologist at Royal North Shore Hospital and Genesis Care and Dr Deme Karikios, Immediate Past Chair of MOGA and Medical Oncologist from Nepean Hospital Sydney join the conversation.
https://jamanetwork.com/journals/jama/article-abstract/2817337 ---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you
enjoyed this episode, please rate and review us on Apple Podcasts or
Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at
https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at
https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn:
https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges
Traditional Owners of Country throughout Australia and recognises the
continuing connection to lands, waters and communities. We pay our
respect to Aboriginal and Torres Strait cultures; and to Elders past and
present.
...more
25min
April 22, 2024 Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
Lung Cancer Support Nurse - Lung Foundation Australia
Quit Centre | Homepage
Lung Cancer Screening Program: Early Detection Saves Lives (thoraciconcology.org.au)
Lung Cancer Optimal Care Pathway
---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
...more
36min
March 27, 2024Underutilisation of Radiotherapy in Lung Cancer Treatment
Radiation therapy can be a very effective treatment for lung cancers, with 77% of patients indicating for radiation therapy in their disease trajectory. Yet, only 40% of patients with lung cancer in NSW receive radiation therapy.
In this podcast, Professor Shalini Vinod, Assoc Professor Mei-Ling Yap, and Dr Clare Bajraszewski discuss why radiation therapy is underutilised in lung cancer, what this means for patients, and potential solutions to address this.
This episode's host are:
Professor Shalini Vinod is a Radiation Oncologist at Liverpool Hospital and a Conjoint Professor at the South Western Sydney Clinical School, UNSW Sydney. She is also on the Board of Directors at TOGA.
Associate Professor Mei-Ling Yap is a senior staff specialist Radiation Oncologist at Liverpool and Macarthur Cancer Therapy Centres in Sydney.
Dr Clare Bajraszewski is a Radiation Oncologist at Peter MacCallum Cancer Centre at the Bendigo campus.
Want to read more about radiation therapy?
Radiation Oncology
Radiation Therapy Treatments
Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia
A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer
---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
...more
25min
February 28, 2024 Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
Artificial intelligence (AI) is transforming medicine. Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly in early diagnosis leading to better patient outcomes. In this podcast we will explore how AI can aid in early detection, accurate interpretation of imaging scans and reduce diagnostic errors. This episode is joined by Associate Professor Michael Franco, a dual trained in medical oncology and palliative care and also the digital health director at Monash in Melbourne. He is featured with Professor Catherine Jones Cardiothoracic Radiologist I-Med Radiology and Clinical Director of Radiology at Redland Hospital, Brisbane and an expert on the Cancer Australia Expert Group for National Lung Cancer Screening Program. And accompanied by Dr Diane Pascoe a Consultant Radiologist and Deputy Director of Medical Imaging at Royal Melbourne Hospital. ---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you
enjoyed this episode, please rate and review us on Apple Podcasts or
Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at
https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at
https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn:
https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges
Traditional Owners of Country throughout Australia and recognises the
continuing connection to lands, waters and communities. We pay our
respect to Aboriginal and Torres Strait cultures; and to Elders past and
present.
...more
31min
December 15, 2023 Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
In this TOGA Podcast the speakers discuss Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer. The discussion explores the different molecules and mechanisms of drugs currently available, trial results and the subsequent place of ADCs in the Lung Cancer. Furthermore, our guests expand upon the management of patients receiving these drugs.

A/Prof Melissa Moore, Medical Oncologist at St Vincent’s Hospital Melbourne, is joined in this conversation by fellow medical oncologists A/Prof Tom John from Peter MacCallum Cancer Centre in Melbourne and A/Prof Adnan Nagrial from Westmead Hospital in Sydney.
---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you
enjoyed this episode, please rate and review us on Apple Podcasts or
Spotify.
---------------
Connect with TOGA
Attend an Event: https://thoraciconcology.org.au/events/
Become a Member: Join the TOGA community at
https://thoraciconcology.org.au/membership/
Donate: Support our research and treatment initiatives at
https://thoraciconcology.org.au/support-us/donate/
Follow Us
LinkedIn:
https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/
X (Twitter): https://x.com/TOGAANZ
Instagram: https://www.instagram.com/togaanz/
YouTube: https://www.youtube.com/@Thoracic_Oncology
---------------
Acknowledgement of Country
The Thoracic Oncology Group of Australasia Limited acknowledges
Traditional Owners of Country throughout Australia and recognises the
continuing connection to lands, waters and communities. We pay our
respect to Aboriginal and Torres Strait cultures; and to Elders past and
present.
...more
30min

FAQs about Conversations in Lung Cancer Research:

How many episodes does Conversations in Lung Cancer Research have?

The podcast currently has 75 episodes available.

More shows like Conversations in Lung Cancer Research

Lung Cancer Considered

29 Listeners

Lung Cancer Rx

3 Listeners

Share Conversations in Lung Cancer Research

Sign up to save your podcasts

Conversations in Lung Cancer Research

FAQs about Conversations in Lung Cancer Research:

How many episodes does Conversations in Lung Cancer Research have?

Conversations in Lung Cancer Research episodes:

FAQs about Conversations in Lung Cancer Research:

How many episodes does Conversations in Lung Cancer Research have?

More shows like Conversations in Lung Cancer Research

Lung Cancer Considered

Lung Cancer Rx